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INTRODUCTION
Monitoring of cardiac output (CO) and invasive hemodynamic 
parameters is useful during major operation. For a long time, 
CO monitoring using thermodilution method with pulmo-
nary artery catheter (PAC) has been considered as a “golden 
standard.” Although this method has been applied as a useful 
hemodynamic monitor in liver transplantation surgery, its in-
vasiveness can be associated with increased morbidity and 
mortality, which may compromise its efficacy in clinical ap-
plication.1-4 For these reasons, Arterial pressure waveform 
analysis and esophageal Doppler were introduced and ap-
plied as less invasive methods for monitoring CO in patients 
undergoing surgery and ICU care.1,5 Thoracic impedance car-
diography (ICG) is a non-invasive and easy-to-apply method 
for continuous CO monitoring that requires attachment of four 
patches to the skin of neck and thoracic wall. ICG evaluates 
CO by measuring changes in electrical resistance of the thorax 
during a cardiac cycle. However, the efficacy of ICG can be 
limited in certain types of surgery, since its measured CO val-
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ues can interfere with several surgical manipulation, volume 
shift including acute bleeding, and electrocautery.6,7
Liver transplantation is a major surgery during which large 
hemodynamic changes may occur. Thermodilution with PAC 
is most commonly used during liver transplantation.8 Al-
though ICG is non-invasive and easy to apply without train-
ing, the results regarding its efficacy and accuracy are conflict-
ing. First of all, ICG has not been validated using thermodilution 
with PAC, which is regarded as a golden standard. Therefore, 
this study aimed to compare the accuracy and efficacy of ICG 
as a non-invasive cardiac function monitoring technique to 
those of thermodilution with PAC and arterial pressure contour.
MATERIALS AND METHODS
Patients and data collection
This retrospective study was approved by the Institutional Re-
view Board (IRB) of Severance Hospital (IRB number: 4-2018-
0560), and the need for written informed consent was waived 
by the IRB. Medical records of all patients who underwent liv-
ing donor liver transplantation at Severance Hospital between 
January and April 2018 were reviewed in this study. Patients 
who underwent cardiac index (CI) measurements using ther-
modilution with PAC, arterial waveform analysis, and ICG 
were included. There were no exclusion criteria. Medical re-
cords were reviewed to obtain patients’ demographic data, 
medical history, and cardiac function parameters.
Cardiac monitoring
In the continuous thermodilution technique, a PAC is equipped 
with an electrical filament wire version of the thermodilution 
catheter, which is positioned in the right ventricle and heats 
the surrounding blood intermittently.1 The temperature change 
in the blood ejected from the right ventricle is detected by a 
thermistor located at the tip of PAC floating freely in the pulmo-
nary artery.6 Continuous thermodilution technique with PAC 
has time delays in CI measurements. PAC’s electric filament 
wire heaters usually cycle every 40–60 seconds. It may take up 
to 12 minutes to fully register CI on the monitor.1 In arterial 
waveform analysis method, the area under the systolic por-
tion of arterial pulse wave from the end of diastole to the end 
of ejection phase is related to stroke volume and CI.9 Arterial 
waveform analysis require calibration, usually with an indica-
tor dilution technique; but recently, self-calibration software 
has been developed for FloTracTM/EV1000TM (Edwards Life-
sciences, Irvine, CA, USA).1 Time for calculating CI depends 
on the method. FloTracTM/EV1000TM (Edwards Lifesciences) 
monitor calculates CI for 20 seconds. ICG estimates CI by 
measuring electrical resistance (impedance) changes across 
the thorax during cardiac cycle. A safe and unrecognizable low-
voltage, high-amplitude current is introduced through the 
sensor, and voltage is sensed through the other sensor. The dif-
ference between the introduced voltage and sensed voltage 
indicates the amount of resistance (impedance) the electrical 
current encounters. Resistance to electrical current in the tho-
rax changes in relation to the amount of blood in the aorta.1 A 
change in impedance is recorded, indicating changes in the 
blood flow in the chest.10 CI measurement time of Niccomo 
ICG monitor is determined by heart rate. In our study, CI 
measurement period was 16 beats. If the patient’s heart rate is 
100, CO measurement for about 9.6 seconds would be dis-
played on the monitor.7
Anesthetic management
During the study period, all patients were managed by stan-
dard anesthesia protocols. After preoxygenation, general an-
esthesia was induced with propofol, sufentanil, and inhaled 
desflurane. Rocuronium was used for neuromuscular block. 
Patients were intubated, and mechanical ventilation was insti-
tuted using volume-controlled ventilation at a tidal volume of 
6–8 mL/kg with 50% oxygen and medical air. Respiratory rate 
was adjusted to within the target of an end-tidal carbon diox-
ide concentration of 35–40 mm Hg. Anesthesia was maintained 
with inhaled desflurane and a continuous infusion of sufent-
anil and cisatracurium. Vascular catheterization was per-
formed in the right radial artery (BD AngiocathTM 20G, Becton 
Dickinson, Heidelberg, Germany), left femoral artery (Arrow 
pediatric jugular catheterization set 20G; Arrow International, 
Reading, PA, USA), and left femoral vein [7-French (Fr) dou-
ble-lumen central venous catheter, Arrow Gard Blue; Arrow 
International]. A 9-Fr large bore central venous catheter (Ad-
vanced Venous Access, Edward Lifesciences, Irvine, CA, USA) 
was placed in the right internal jugular vein, and a PAC (Swan-
Ganz CCOmbo V, Edward Lifesciences) was inserted.
Radial artery catheter was connected to FloTracTM/EV1000TM 
system device (Edwards Lifesciences). PAC was connected to 
Vigilance II Monitor (Edwards Lifesciences) to measure con-
tinuous CO/index by thermodilution technique. In addition, 
the electrodes of NiccomoTM ICG monitor (Medis, Ilmenau, Ger-
many) were attached on the left side of the patient’s neck and 
the midaxillary line of left chest at the level of xiphoid process. 
Then, four electrodes were connected to NiccomoTM device 
(Medis) to measure CO/index and hemodynamic parameters. 
After induction of anesthesia, simultaneously measured CIs 
were recorded in the patient’s anesthesia records every hour 
until the end of operation.
 
Statistical analysis
The patients’ demographic characteristics are presented as 
mean±standard deviation (SD), median (first quartile-third 
quartile), or number (percentage). The normality of continu-
ous variables was tested using Kolmogorov-Smirnov test. Sta-
tistical analysis of CI was performed using intraclass correla-
tion coefficient (ICC), and Bland-Altman analysis was used to 
assess the degree of agreement between the measured CIs 
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provided by two of the three cardiac monitoring methods. ICC 
represents agreement classified as almost perfect (0.81–1.00), 
substantial (0.61–0.80), moderate (0.41–0.60), fair (0.20–0.40), 
and slight (<0.20).11 Bland-Altman analysis was used to calcu-
late the mean and difference in each pair of measurements, 
with the mean being x-axis and the difference being y-axis. 
According to the mean and SD of the differences in CI, 95% of 
the differences were between mean±1.96 SD.12 In Bland-Alt-
man analysis, the percentage error could be calculated by dou-
bling SD of bias divided by the mean CI. When the percentage 
error was less than 30%, the two methods were considered 
clinically equivalent.9,13 All statistical analyses were performed 
using SAS (version 9.4, SAS Inc., Cary, NC, USA) and R version 
3.3.0 (The R Foundation for Statistical Computing, Vienna, 
Austria).
RESULTS
Sixteen patients with 220 paired CI were enrolled in this study. 
Demographic characteristics of the patients are shown in Ta-
ble 1. Mean (±SD) CI of thermodilution with PAC was 4.4±1.21 
L/min/m2, while that of arterial pressure waveform analysis 
was 4.0±1.06 L/min/m2 and that of ICG was 3.3±0.88 L/min/m2. 
The range of CO and CI measurements from thermodilution 
with PAC, arterial waveform analysis, and ICG were 3.7–16.7 
L/min and 2.1–8.8 L/min/m2, 2.2–13.6 L/min and 1.6–5.5 L/
min/m2, and 2.6–13.0 L/min and 1.6–5.5 L/min/m2, respec-
tively. 
Table 1. Demographic Characteristics of the Patients (n=16)
Characteristics Value
Age (yr) 58.13±11.38
Sex (male/female) 12/4
Height (cm) 165.79±8.30
Weight (kg) 66.35±12.64
BMI (kg/m2) 23.84±3.44
BSA (m2) 1.74±0.20
MELD 10.50 (7.21–14.76)
CTP class (A/B/C) 7/4/5
EF (%) 71.38±5.33
Cr (mg/dL) 0.83±0.26
Preop SBP (mm Hg) 125.0 (121.3–137.0)
Preop DBP (mm Hg) 76.0 (70.0–83.5)
BMI, body mass index; BSA, body surface area; MELD, Model for End-Stage 
Liver Disease; CTP, Child-Turcotte-Pugh; EF, ejection fraction; Cr, creatinine; 
SBP, systolic blood pressure; DBP: diastolic blood pressure.
Data are presented as mean±standard deviation, median (interquartile 
range), or number of patients.
Table 2. Intraclass Correlation Coefficient between Diagnostic Modalities Measuring Cardiac Index according to the Three Phases of Liver Trans-
plantation
ICC between diagnostic modalities
PAC and ICG PAC and FloTrac FloTrac and ICG
Overall 0.560 (0.463–0.640) 0.580 (0.480–0.660) 0.533 (0.369–0.666)
Preanhepatic 0.680 (0.559–0.770) 0.670 (0.550–0.760) 0.590 (0.450–0.700)
Anhepatic 0.630 (0.425–0.770) 0.540 (0.300–0.710 0.620 (0.400–0.760)
Neohepatic 0.420 (0.210–0.600) 0.470 (0.263–0.630) 0.310 (0.077–0.510)
ICC, intraclass correlation coefficient; PAC, pulmonary artery catheter; ICG, impedance cardiography; FloTrac, arterial waveform analysis; Preanhepatic, from skin 
incision to exclusion of liver circulation; Anhepatic, from exclusion of liver circulation to graft reperfusion; Neohepatic, from graft reperfusion to the end of sur-
gery.
ICCs are provided with 95% confidence intervals.
Fig. 1. Bland-Altman plot between diagnostic modalities measuring cardiac output in liver transplantation. (A) Bland-Altman plot between thermodilution 
with pulmonary artery catheter (PAC) and impedance cardiography (ICG). (B) Bland-Altman plot between thermodilution with PAC and arterial waveform 
analysis (FloTrac). (C) Bland-Altman plot between FloTrac and ICG.
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Moderate agreement was observed between two of the three 
methods when analyzed on the basis of ICC (Table 2). In sub-
group analysis according to preanhepatic phase, anhepatic 
phase, and neohepatic phase, substantial agreement was ob-
served between CI of thermodilution with PAC and ICG at pre-
anhepatic and anhepatic phases, and between CI of thermo-
dilution with PAC and arterial waveform analysis only at 
preanhepatic phase (Table 2).
The bias of CI of thermodilution with PAC and ICG was 1.13 
L/min/m2, and the lower and upper limits of agreement were 
-0.93 L/min/m2 and 3.20 L/min/m2, respectively. Percentage 
error was 94.7%, which exceeded the 30% limit of acceptance. 
The bias of CI of thermodilution with PAC and arterial pres-
sure contour was 0.62 L/min/m2, and the lower and upper 
limits of agreement were -1.43 L/min/m2 and 2.67 L/min/m2, 
respectively, with a percentage error of 93.4%. The bias of CI 
of arterial pressure contour and ICG was 0.50 L/min/m2, and 
the lower and upper limits of agreement were -1.32 L/min/m2 
and 2.32 L/min/m2, respectively, with a percentage error of 
91.6% (Fig. 1). In subgroup analysis according to preanhepatic 
phase, anhepatic phase, and neohepatic phase, all of the per-
centage of error between diagnostic modalities were greater 
than 30% (Table 3, Figs. 2-4).
Table 3. Percentage Error of Bland-Altman Plot between Diagnostic 
Modalities Measuring Cardiac Index according to the Three Phases of 
Liver Transplantation
Percentage error between diagnostic modalities
PAC and ICG PAC and FloTrac FloTrac and ICG
Overall 94.7 93.4 91.6
Preanhepatic 61.9 88.4 77.5
Anhepatic 98.1 98.3 82.4
Neohepatic 108.5 103.9 107.3
PAC, pulmonary artery catheter; ICG, impedance cardiography; FloTrac, arte-
rial waveform analysis; Preanhepatic, from skin incision to exclusion of liver 
circulation; Anhepatic, from exclusion of liver circulation to graft reperfusion; 
Neohepatic, from graft reperfusion to the end of surgery.
Fig. 2. Bland-Altman plot between diagnostic modalities measuring cardiac output in preanhepatic phase. (A) Bland-Altman plot between thermodilution 
with pulmonary artery catheter (PAC) and impedance cardiography (ICG). (B) Bland-Altman plot between thermodilution with PAC and arterial waveform 
analysis (FloTrac). (C) Bland-Altman plot between FloTrac and ICG.
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Fig. 3. Bland-Altman plot between diagnostic modalities measuring cardiac output in anhepatic phase. (A) Bland-Altman plot between thermodilution 
with pulmonary artery catheter (PAC) and impedance cardiography (ICG). (B) Bland-Altman plot between thermodilution with PAC and arterial waveform 
analysis (FloTrac). (C) Bland-Altman plot between FloTrac and ICG.
4
3
2
1
0
-1
4
2
0
-2
2
1
0
-1
2           3            4           5            6             7  2              3             4              5             6 2              3            4             5            6
Mean of PAC and ICG Mean of PAC and FloTrac Mean of FloTrac and ICG
Di
ffe
re
nc
e 
be
tw
ee
n 
PA
C 
an
d 
IC
G
Di
ffe
re
nc
e 
be
tw
ee
n 
PA
C 
an
d 
Flo
Tr
ac
Di
ffe
re
nc
e 
be
tw
ee
n 
Flo
Tr
ac
 a
nd
 IC
G
A B C
739
Go Eun Kim, et al.
https://doi.org/10.3349/ymj.2019.60.8.735
DISCUSSION
 
This is the first study to simultaneously compare ICG with 
thermodilution with PAC and arterial pressure contour during 
liver transplantation. This study showed that, although ther-
modilution, arterial pressure contour, and ICG showed simi-
lar moderate agreement, ICG and arterial pressure contour 
are not clinically equivalent with PAC in liver transplantation. 
 Traditionally, PAC has been used to measure invasive hemo-
dynamic parameters in high-risk patients undergoing major 
surgery.14-17 However, PAC may be inaccurate if it is not posi-
tioned correctly, and it does not reflect the change in intravas-
cular volume rapidly enough. In addition, risks of PAC insertion, 
such as pulmonary artery rupture and ventricular arrhythmia, 
have been reported.4,18-21 PAC is less frequently used than before, 
as minimally invasive monitoring tools can be used instead of 
PAC.22,23 Arterial pulse waveform analysis is a less invasive CO 
measurement method. However, in patients with cirrhosis of 
Child-Pugh classes B and C, arterial pressure waveform anal-
ysis system had little correlation with thermodilution with 
PAC. In liver cirrhosis with Child-Pugh classes B and C, the 
degree of inaccuracy was proportional to the patient’s system-
ic vascular resistance, indicating less correlation with PAC. 
Arterial pulse waveform analysis underestimated CO in liver 
transplant patients with CO exceeding 8 L/min.15 Despite 
these features, arterial waveform analysis has been increasingly 
used in various surgeries for monitoring cardiac function.
ICG involves the application of thoracic electrical bioimped-
ance (TEB) technology, which determines CO by measuring 
changes in TEB during the cardiac cycle. Electrodes are attached 
onto the root of the neck and thorax. A safe, undetectable, low-
voltage, high-amplitude alternating current is introduced 
through the outermost sensor, and the voltage is sensed through 
the innermost sensor. The difference between the introduced 
voltage and the sensed voltage is the amount of resistance (im-
pedance). Resistance (impedance) to the current in the thorax 
changes with the amount of blood in the aorta. ICG measures 
these changes over time as a volume waveform similar to an 
arterial pressure waveform.6 It has the advantage of being a 
non-invasive, cost-effective, operator-independent method 
that is also capable of stable measurements in both upright 
and supine positions. Non-invasive hemodynamic CO moni-
toring method can allow hemodynamic optimization strate-
gies in low- or intermediate-risk surgical patients, or patients 
undergoing diagnostic or therapeutic procedures such as en-
doscopy or interventional radiology procedures.24 It can also 
enable continuous real-time monitoring of cardio-circulatory 
variations.25 The trending ability of continuous CO monitoring 
device may be more helpful in the management and optimi-
zation of hemodynamics, as the patient’s hemodynamic sta-
tus and response can change under major surgeries.26 Studies 
of ICG have reported conflicting results and are difficult to 
compare, since they have been performed using devices of 
different generations in patients with different characteristics, 
while also using different equations.27 The accuracy of ICG 
decreases when a rapid change occurs in abrupt hemodynamic 
loading.28
Time for calculating CO depends on the method. FloTracTM/
EV1000TM monitor (Edwards Lifesciences) calculates CO for 
20 seconds. CO measurement time of NiccomoTM ICG monitor 
(Medis) is determined by the heart rate. In the current study, 
the period for measuring CO was 16 heartbeats. Continuous 
thermodilution technique using PAC has a time delay in mea-
suring CO. Electric filament wire heater of PAC is usually cy-
cled every 40–60 seconds. It may take up to 12 minutes for CO 
to be fully registered on the monitor, as it is averaged with the 
goal of reducing noise and improving reliability.1 Therefore, 
the continuous thermodilution method may not detect sud-
den changes in CO compared to arterial pressure waveform 
analysis or ICG. In our study, the bias between arterial pres-
sure waveform analysis and ICG, which have a relatively short 
time interval for measuring CI compared to PAC, was 0.50 L/
Fig. 4. Bland-Altman plot between diagnostic modalities measuring cardiac output in neohepatic phase. (A) Bland-Altman plot between thermodilution 
with pulmonary artery catheter (PAC) and impedance cardiography (ICG). (B) Bland-Altman plot between thermodilution with PAC and arterial waveform 
analysis (FloTrac). (C) Bland-Altman plot between FloTrac and ICG.
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min/m2. This bias was lower than that between thermodilu-
tion with PAC and the other two methods; bias between PAC 
and ICG was 1.13 L/min/m2, and that between PAC and arte-
rial pressure waveform analysis was 0.62 L/min/m2. This re-
sult may have been due to the difference in the time of CO 
measurement among the three methods.
Since ICG reads electrocardiographic parameters and tho-
racic impedance through electrodes to measure CO, the CO 
values cannot be obtained while electrocautery is used. When 
the use of electrocautery is discontinued, the display of CO is 
delayed until a set number of heartbeats has passed.7 On the 
other hand, PAC and arterial waveform analysis are not affect-
ed by electrocautery. Therefore, the values measured by ICG 
around the use of electrocautery may be relatively unreliable; 
however, those measured by thermodilution or arterial pulse 
contour analyses may be more reliable during the use of elec-
trocautery.
On Bland-Altman analysis, the percentage error of thermo-
dilution with PAC and arterial waveform analysis was more 
than 30%, although ICC showed moderate agreement. How-
ever, both thermodilution with PAC and arterial waveform 
analysis are widely used in major surgeries, including liver 
transplantation. Thermodilution with PAC and ICG also showed 
a percentage error above 30%, and a moderate-to-substantial 
degree of agreement on the basis of ICC. Although both ICG 
and arterial waveform analysis are not clinically equivalent to 
thermodilution, ICG has a better correlation with thermodilu-
tion than arterial waveform analysis at preanhepatic and an-
hepatic phases. ICG might be more useful as a non-invasive 
cardiac function monitor than arterial waveform analysis in 
the case of high-risk patients undergoing minor surgery. More 
studies on these types of situations are required. 
This study had some limitations. First, the number of patients 
was small (n=16). The median number of patients in recent 
studies on ICG was 28 (range 21–45). However, 220 paired CIs 
were included in our study, which was more than the median 
of data in other studies: 97 (interquartile range 36–158) pairs.29 
Second, we used continuous thermodilution instead of inter-
mittent bolus thermodilution. Although intermittent pulmo-
nary artery thermodilution is often referred to as the clinical 
“golden standard,” its accuracy depends on operator variation, 
patient pathologies, and the indicator used. According to pre-
vious studies, continuous and intermittent thermodilution 
have shown acceptable limits of agreement during major sur-
geries.30-32 Previous studies demonstrated that during liver 
transplantation, the correlation between intermittent and con-
tinuous thermodilution CO measurements was significant (r= 
0.87–0.92).30,33 Therefore, continuous thermodilution in this 
study was appropriate for determining CO measurement. 
Third, there may be possible bias due to the discrepancy of mea-
surement timing of three different modalities. Inconsistencies 
in timing during recording may occur, since one anesthesiolo-
gist records the CO calculated from the three modalities si-
multaneously on anesthesia record.
In conclusion, although neither method was clinically equiv-
alent to thermodilution, ICG showed more substantial corre-
lation with thermodilution method than with arterial wave-
form analysis. As a non-invasive cardiac function monitor, ICG 
would likely require further studies in other settings.
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